Up to date news from the Centre for Discovery Brain Sciences.
Prof Tom Gillingwater elected as Fellow of the Royal Society of Edinburgh
Congratulations to Professor Tom Gillingwater, who becomes a Fellow of The Royal Society in recognition of outstanding contributions across Anatomical research, education, engagement and wider knowledge exchange.
2020 Edinburgh Brain Bee promotes brain science to High School pupils
A group of University of Edinburgh students and neuroscientists including Dr Dorothy Tse (Centre for Discovery Brain Sciences) organised the annual Edinburgh Brain Bee competition, which was held at the University of Edinburgh on 22 February 2020. Dr Jennifer Paxton, a lecturer in anatomy gave a talk on anatomy and tissue engineering. The event was funded by the Principal's Teaching Award Scheme at the University of Edinburgh and also supported by Edinburgh Neuroscience.
New book by Prof Gareth Leng
Congratulations to Professor Gareth Leng (Centre for Discovery Brain Sciences) and his son Dr Rhodri Leng (School of Social Sciences) who have published a new book called The Matter of Facts - which explores how scientists produce and use evidence.
Dr Barry McColl awarded Brain Research UK funding
Manipulating microglial/macrophage function via CSF1R to improve functional recovery and neuroplasticity after stroke.
McColl Lab in Fondation Leducq consortium
McColl Lab one of 11 members forming a transatlantic network funded by 5y $6M grant to investigate the role of neuroimmune mechanisms influencing cognitive trajectory after stroke.
Doitsidou Lab identify protective gut bacteria in a C. elegans Parkinson's model
Paper "Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans" is now online on Cell Reports.
Landmark trial seeks people with MND to test potential treatments
Hundreds of people living with motor neurone disease are being invited to take part in one of the UK’s most comprehensive clinical trials in a generation. The UK-wide trial – called MND-SMART – aims to find treatments that can slow, stop or reverse disease progression. The long-term study will ensure that new medicines can be tested for years to come, researchers say.